MHS
ALXN

M Holdings Securities’s Alexion Pharmaceuticals ALXN Stock Holding History

M Holdings Securities’s Portfolio ALXN Stock Details ALXN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-2,161
Closed -$330K – 506
2021
Q1 		$330K Buy
+2,161
New +$334K 0.03% 363
2014
Q4 		– Sell
-200
Closed -$33K – 468
2014
Q3 		$33K Buy
+200
New +$32.8K 0.02% 444

Other funds holding ALXN

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
HI
HBK Investments Dallas, Texas $9.85B AUM 55.6% 1-Year Est. Return
DKCM
Davidson Kempner Capital Management New York $7.33B AUM 56.47% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
UOC
UBS O'Connor Chicago, Illinois $3.38B AUM 63.08% 1-Year Est. Return

M Holdings Securities's ALXN Position: Q2 2021 in Review

M Holdings Securities sold out of Alexion Pharmaceuticals (ALXN) in Q2 2021, closing a stake of 2,161 shares — an estimated $330K sold.

M Holdings Securities first reported a position in ALXN in Q3 2014 and held it in 2 quarters. The position peaked at $330K in Q1 2021. 707 funds tracked by Wall St. Rank hold ALXN as of Q2 2021.

  • M Holdings Securities reported no remaining Alexion Pharmaceuticals position as of Q2 2021 after selling out during the quarter.
  • M Holdings Securities sold 2,161 Alexion Pharmaceuticals shares in Q2 2021, an estimated $330K.
  • M Holdings Securities first reported a position in Alexion Pharmaceuticals in Q3 2014 and held it in 2 quarters.
  • M Holdings Securities's Alexion Pharmaceuticals position peaked at $330K in Q1 2021.
  • 707 funds tracked by Wall St. Rank held Alexion Pharmaceuticals as of Q2 2021.

Based on M Holdings Securities's 13F filing for Q2 2021, filed 19 Aug 2021.